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Dear Editor
Current therapeutical options for cocaine craving are still limited, 
favoring the seek for solutions in Complementary and Alternative 
Medicine (CAM). Homeopathy is a CAM modality recognized as a 
medical specialty in Brazil. Homeopathic medicines are produced 
through sequentially agitated dilutions in decimal (D), centesimal (C) 
or fifty-millesimal (Quinquagintamillesimal, Q or LM) potencies1. 
The efficacy or effectiveness of homeopathic remedies for cocaine de-
pendency has not yet been investigated. We conducted an exploratory 
randomized, placebo controlled, double-blind 4-week clinical trial 
aiming at assessing the efficacy and tolerability of the homeopathic 
medicines Opium and Erythroxylum coca in the complementary 
treatment of cocaine craving. The study was carried out in São Paulo, 
in the so called “cracolândia” area, at the Centro de Referência de 
Álcool, Tabaco e Outras Drogas (CRATOD), with the approval of the 
Ethics Committee of Universidade Federal de São Paulo (Unifesp). 
Trial Registration: RBR-67zvt5 (Brazilian Clinical Trials Registry). 
Patients: Between January and November 2012, 42 patients with a 
diagnosis of cocaine dependency according to DSM-IV TR criteria 
were included. The study was interrupted due to low adherence. The 
majority of participants were unemployed (88%), living in shelters 
or on the streets of São Paulo downtown area. Interventions: In the 
homeopathy group patients were treated at CRATOD with conven-
tional treatment and Opium 2 LM, 1 daily sucrose globule melted 
on the tongue, during the first two weeks, and Erythroxylum coca 
2 LM, same dosage, in the following two weeks. Comparison: In 
the placebo group patients received conventional treatment and 1 
sucrose globule a day for the four weeks. During the period of the 
study, conventional treatment at CRATOD included therapeutic 
and income generation workshops; motivational groups; group 
and individual psychotherapies; medical treatment of substance 
dependency and of clinical/psychiatric comorbidities. Results: Out 
of the 42 included patients, only 23 (54.8%) returned at least once 
and were considered for statistical analysis. Twelve patients (52%) 
were randomized to group 1 (homeopathy) and 11 (48%) to group 
2 (placebo). No significant between-group differences were found 
regarding efficacy (Minnesota Cocaine Craving Scale2) or side effects 
(Scandinavian Society of Psychopharmacology Side Effect Rating 
Scale3). Within the homeopathy group, analysis suggests a reduction 
in the frequency of longer craving episodes and an increased sensa-
tion that the medicine contributed to the reduction of craving (final 
results compared to baseline – Table 1). Larger samples of patients 
with higher adherence are necessary to evaluate these differences, 
not observed in the placebo group.
Table 1. Percentage of patients reporting craving episodes > 20 minutes and the sensation that the medicine has contributed to the reduction of craving 
% reporting craving episodes > 20 minutes
Groups Week 0 Week 1 Week 2 Week 3 Week 4
Homeopathy – mean 
(95% CI)
79.8 
(64.3; 92.9)
16.3 
(3.4; 33.0)* 
35.1 
(16.3; 59.3)* 
37.2
 (11.4; 65.6)*
35.6 
(12.0; 58.7)*
Placebo – mean
(95% CI)
53.6 
(37.6; 70.3)
31.0 
(16.1; 48.9)
61.0
 (34.6; 84.5)
35.4
 (14.7; 57.1)
41.1 
(22.1; 61.2)
Ratio
(95% CI)
1.5 
(1.1; 2.2)*
0.5
 (0.1; 1.4)
0.6 
(0.2; 1.2)
1.2 
(0.2; 2.9)
0.9 
(0.2; 1.9)
% reporting the sensation that the medicine has contributed to the reduction of craving
Homeopathy – mean 
(95% CI)
- 24.5 
(5.0; 51.9)
65.9
 (66.6; 89.2)*
91.7 
(64.0; 99.9)*
67.4 
(33.3; 93.0)*
Placebo – mean
(95% CI)
- 55.0 
(2.7; 81.2)
68.9 
(34.5; 93.3)
72.3 
(41.0; 94.1)
74.3 
(45.0; 95.0)
Ratio
(95% CI)
- 0.4 
(0.1; 1.2)
1.0 
(0.5; 2.0)
1.3 
(0.8; 2.3)
0.9 
(0.4; 1.7)
* Statistically different from basal week.
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